Kiniksa Pharmaceuticals (KNSA)
(Delayed Data from NSDQ)
$16.88 USD
-0.07 (-0.41%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $16.87 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO4/23/24 |
---|---|
Current Quarter | -0.14 |
EPS Last Quarter | 0.04 |
Last EPS Surprise | 136.36% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.06 |
Next Year | -0.45 |
EPS (TTM) | -0.36 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 76.75M | 87.02M | 369.83M | 472.15M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 78.42M | 87.73M | 373.31M | 498.83M |
Low Estimate | 75.08M | 86.30M | 366.34M | 445.47M |
Year ago Sales | 48.35M | 71.47M | 270.26M | 369.83M |
Year over Year Growth Est. | 58.74% | 21.75% | 36.84% | 27.67% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.14 | -0.11 | -0.06 | -0.45 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | NA | NA | -0.67 | -0.65 |
High Estimate | -0.13 | -0.05 | 0.75 | -0.24 |
Low Estimate | -0.14 | -0.16 | -0.67 | -0.65 |
Year ago EPS | -0.18 | -0.02 | -0.34 | -0.06 |
Year over Year Growth Est. | 22.22% | -450.00% | 82.35% | -647.22% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.14 | -0.11 | -0.06 | -0.45 |
7 Days Ago | -0.14 | -0.11 | -0.06 | -0.45 |
30 Days Ago | -0.14 | -0.11 | -0.05 | -0.43 |
60 Days Ago | -0.18 | -0.15 | -0.11 | -0.18 |
90 Days Ago | -0.20 | -0.22 | -0.26 | -0.40 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.14 | -0.11 | -0.67 | -0.65 |
Zacks Consensus Estimate | -0.14 | -0.11 | -0.06 | -0.45 |
Earnings ESP | 0.00% | 0.00% | -1,082.35% | -46.07% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.04 | -0.20 | -0.02 | -0.18 | NA |
Estimate | -0.11 | -0.18 | -0.16 | -0.18 | NA |
Difference | 0.15 | -0.02 | 0.14 | 0.00 | 0.07 |
Surprise | 136.36% | -11.11% | 87.50% | 0.00% | 53.19% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more